LabCorp Enters Into License Agreement with Sequella

News   Oct 24, 2012

 
LabCorp Enters Into License Agreement with Sequella
 
 
 

RELATED ARTICLES

Infrared Spectroscopy Test Can Diagnose Two Cancer Types

News

Researchers used mid-infrared spectroscopy to analyze blood serum derived from experimental mice and differentiate mice with non-Hodgkin’s lymphoma and subcutaneous melanoma from healthy mice and also between these two tumorous conditions.

READ MORE

Medicinal Compound in Plant Roots Examined

News

A New Phytologist study sheds light on the sites of synthesis and accumulation of xanthones in roots. The findings may be helpful for understanding the biosynthesis of xanthones and in efforts to manipulate them for medicinal purposes.

READ MORE

Tapeworm Drug Molecule Could Aid Fight Against Parkinson’s Disease

News

Researchers have identified a drug molecule within a medicine used to treat tapeworm infections which could lead to new treatments for patients with Parkinson's disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE